• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Stereotactic Body Radiation Therapy-Induced Abscopal Effect on Hepatocellular Carcinoma After Treatment for Lung Cancer: A Case Report.

作者信息

Chino Fumiko, Pollis Kimberly Ellen, Choi Steve, Salama Joseph K, Palta Manisha

机构信息

Department of Radiation Oncology, Duke University.

Durham Veterans Affairs Medical Center.

出版信息

Hepatology. 2018 Oct;68(4):1653-1655. doi: 10.1002/hep.30100.

DOI:10.1002/hep.30100
PMID:29888796
Abstract
摘要

相似文献

1
Stereotactic Body Radiation Therapy-Induced Abscopal Effect on Hepatocellular Carcinoma After Treatment for Lung Cancer: A Case Report.立体定向体部放射治疗对肺癌治疗后肝细胞癌产生的远隔效应：一例报告
Hepatology. 2018 Oct;68(4):1653-1655. doi: 10.1002/hep.30100.
2
Pretreatment F-fluorodeoxyglucose Uptake in the Lung Parenchyma Predicts Poor Survival After Stereotactic Body Radiation Therapy in Patients With Stage I Non-Small Cell Lung Cancer.I期非小细胞肺癌患者肺实质的预处理氟脱氧葡萄糖摄取情况可预测立体定向体部放射治疗后的不良生存结局。
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818794934. doi: 10.1177/1533033818794934.
3
Dosimetric Comparison of Real-Time MRI-Guided Tri-Cobalt-60 Versus Linear Accelerator-Based Stereotactic Body Radiation Therapy Lung Cancer Plans.实时MRI引导的三钴-60与基于直线加速器的立体定向体部放射治疗肺癌计划的剂量学比较
Technol Cancer Res Treat. 2017 Jun;16(3):366-372. doi: 10.1177/1533034617691407. Epub 2017 Feb 7.
4
Stereotactic body radiation therapy (SBRT) for lung and liver tumours.
J Indian Med Assoc. 2012 Jul;110(7):462-4.
5
Update of a Prospective Study of Stereotactic Body Radiation Therapy for Post-Chemoradiation Residual Disease in Stage II/III Non-Small Cell Lung Cancer.Ⅱ/Ⅲ期非小细胞肺癌放化疗后残留病变立体定向体部放疗的前瞻性研究更新。
Int J Radiat Oncol Biol Phys. 2017 Nov 1;99(3):652-659. doi: 10.1016/j.ijrobp.2017.07.036. Epub 2017 Jul 29.
6
Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non-Small Cell Lung Cancer.无法手术的 I 期非小细胞肺癌立体定向体部放疗的长期结果。
JAMA Oncol. 2018 Sep 1;4(9):1287-1288. doi: 10.1001/jamaoncol.2018.1258.
7
Early PET-CT After Stereotactic Radiotherapy for Stage 1 Non-small Cell Lung Carcinoma Is Predictive of Local Control.立体定向放射治疗后早期PET-CT对Ⅰ期非小细胞肺癌局部控制具有预测价值。
In Vivo. 2018 Jan-Feb;32(1):121-124. doi: 10.21873/invivo.11213.
8
Image-based management of empiric lung stereotactic body radiotherapy (SBRT) without biopsy: Predictors from a 10-year single institution experience.基于影像的经验性肺立体定向体部放疗（SBRT）无活检管理：来自单机构 10 年经验的预测因素。
Thorac Cancer. 2018 Jun;9(6):699-706. doi: 10.1111/1759-7714.12635. Epub 2018 Apr 26.
9
Reirradiation of recurrent node-positive non-small cell lung cancer after previous stereotactic radiotherapy for stage I disease : A multi-institutional treatment recommendation.先前接受立体定向放射治疗的 I 期复发性淋巴结阳性非小细胞肺癌再照射：多机构治疗建议。
Strahlenther Onkol. 2017 Jul;193(7):515-524. doi: 10.1007/s00066-017-1130-0. Epub 2017 Apr 19.
10
Accelerated Hypofractionated Radiotherapy Versus Stereotactic Body Radiotherapy for the Treatment of Stage I Nonsmall Cell Lung Cancer-A Single Institution Experience With Long-Term Follow-Up.加速超分割放疗与立体定向体部放疗治疗Ⅰ期非小细胞肺癌——单机构长期随访经验
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818806318. doi: 10.1177/1533033818806318.

引用本文的文献

1
Non-targeted effects of stereotactic radiotherapy: a review of the evidence coming from the clinical field.立体定向放射治疗的非靶向效应：来自临床领域证据的综述
Explor Target Antitumor Ther. 2025 Feb 13;6:1002290. doi: 10.37349/etat.2025.1002290. eCollection 2025.
2
Immunotherapy and Radiation Therapy Combinatorial Approaches in Hepatocellular Carcinoma.肝细胞癌的免疫治疗与放射治疗联合方法
Cancers (Basel). 2024 Mar 5;16(5):1058. doi: 10.3390/cancers16051058.
3
Abscopal Effect on Bone Metastases from Solid Tumors: A Systematic Review and Retrospective Analysis of Challenge within a Challenge.
实体瘤骨转移的远隔效应：挑战中的挑战之系统评价与回顾性分析
Biomedicines. 2023 Apr 12;11(4):1157. doi: 10.3390/biomedicines11041157.
4
A Patient-Level Data Meta-analysis of the Abscopal Effect.远隔效应的患者水平数据荟萃分析。
Adv Radiat Oncol. 2022 Mar 3;7(3):100909. doi: 10.1016/j.adro.2022.100909. eCollection 2022 May-Jun.
5
Spontaneous regression of metastatic hepatocellular carcinoma following 3 weeks of lenvatinib.仑伐替尼治疗 3 周后转移性肝细胞癌自发消退。
BMJ Case Rep. 2022 Feb 9;15(2):e247212. doi: 10.1136/bcr-2021-247212.
6
Abscopal Effects in Metastatic Cancer: Is a Predictive Approach Possible to Improve Individual Outcomes?转移性癌症中的远隔效应：是否有可能采用预测性方法来改善个体治疗结果？
J Clin Med. 2021 Oct 31;10(21):5124. doi: 10.3390/jcm10215124.
7
Exploring the mythical abscopal effect: Radiation and programmed cell death protein 1 (PD-1) blockade for hepatocellular carcinoma.探索神秘的远隔效应：放射治疗与程序性细胞死亡蛋白1（PD-1）阻断疗法用于肝细胞癌治疗
Clin Mol Hepatol. 2021 Jan;27(1):103-106. doi: 10.3350/cmh.2020.0297. Epub 2020 Dec 14.
8
Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapy.回顾性分析肝细胞癌经动脉区域性局部治疗的免疫效应：选择性内放射治疗（SIRT）联合免疫治疗的原理。
BMC Cancer. 2020 Feb 19;20(1):135. doi: 10.1186/s12885-020-6613-1.
9
The promise of adoptive cellular immunotherapies in hepatocellular carcinoma.过继性细胞免疫疗法在肝细胞癌治疗中的前景。
Oncoimmunology. 2019 Oct 13;9(1):1673129. doi: 10.1080/2162402X.2019.1673129. eCollection 2020.